Efficacy of PD-1/PD-L1 inhibitor-based therapies in refractory microsatellite instability (MSI)-unselected metastatic colorectal cancer (mCRC): A network meta-analysis (NMA) of randomized controlled trials (RCTs).

Zi Xian Wang,Yu Tong Chen,Yixin Zhou,Hao Xiang Wu,Zhan-Hong Chen,Tian-Tian Wang,Xiang Yuan Wu,Feng Wang,Rui Hua Xu

Efficacy of PD-1/PD-L1 inhibitor-based therapies in refractory microsatellite instability (MSI)-unselected metastatic colorectal cancer (mCRC): A network meta-analysis (NMA) of randomized controlled trials (RCTs).

2019

Zi Xian Wang
Yu Tong Chen
Yixin Zhou
Hao Xiang Wu
Zhan-Hong Chen
Tian-Tian Wang
Xiang Yuan Wu
Feng Wang
Rui Hua Xu

e15048Background: PD-1/PD-L1 inhibitor-based monotherapies and combination therapies are being investigated to challenge microsatellite stable (MSS) mCRC. This NMA aimed to assess the efficacy of a...

Keywords:

Meta-analysis
Refractory
Oncology
Randomized controlled trial
Colorectal cancer
Pathology
PD-L1 inhibitor
Microsatellite instability
Medicine
Internal medicine
Microsatellite Stable

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations